Evidence map›Paper›PMID 21441130›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2011

Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.

Emmanuel Letavernier, Olivier Traxer, Michel Daudon, Mohammed Tligui, Jérôme Hubert-Brierre, Dominique Guerrot, Aline Sebag, Laurent Baud, Jean-Philippe Haymann

Open access · greenAbstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Pediatric Nephrolithiasis.Healthcare (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Article
  12. UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Vascular calcification and bone mineral density in recurrent kidney stone formers.Clinical journal of the American Society of Nephrology : CJASN · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Emmanuel LetavernierService des Explorations Fonctionnelles Multidisciplinaires, Hôpital Tenon, 4 Rue de la Chine, 75020 Paris, France. emmanuel.letavernier@tnn.aphp.fr
Olivier Traxer
Michel Daudon
Mohammed Tligui
Jérôme Hubert-Brierre
Dominique Guerrot
Aline Sebag
Laurent Baud
Jean-Philippe Haymann
Sorbonne Université · FRHôpital Tenon · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Necker-Enfants Malades · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesBone demineralization is frequent in renal-stone formers with hypercalciuria. Although this pathologic link has been recognized for decades, the underlying mechanisms and risk factors associated with osteopenia/osteoporosis in this population remain partially understood. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study retrospectively analyzed determinants of low bone mineral density (BMD) in 65 idiopathic hypercalciuric male renal-stone formers. Clinical and biologic evaluation included BMD measurement, bone-remodeling markers, analysis of calcium metabolism with oral calcium load test, and dietary inquiry.

resultsPatients with osteopenia (n=23, 35% of the population) presented significantly higher fasting calciuria as compared with normal bone density patients (n=42) (calcium/creatinine ratio was 0.32 versus 0.24 mmol/mmol; P=0.006). Analysis of the whole population revealed a negative association between fasting hypercalciuria and BMD (P = 0.003), independent of confounding variables including body-mass index and tobacco consumption. The fasting calcium/creatinine ratio above 0.25 mmol/mmol was associated with a 3.8-fold increase in the risk of low BMD.

conclusionIn our study, fasting hypercalciuria after a 2-day calcium-restricted diet appears as the only biologic factor associated with low BMD, suggesting a bone-calcium efflux. Our results support the view of a parathyroid-independent pathologic process that remains to be identified. Hypercalciuric patients with low BMD do not excrete more calcium in 24-hour urine samples than patients without low BMD.

Indexed as

Bone Diseases, MetabolicHypercalciuriaKidney CalculiOsteoporosisAdultCalcification, PhysiologicCalciumCalcium, DietaryHumansLogistic ModelsMaleMiddle AgedRetrospective StudiesRisk FactorsSensitivity and SpecificityCalciumCalcium, Dietary

Identifiers

PMID21441130
PMCPMC3087782
OpenAlexW2169267651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.